Advertisement

Topics

Avedro Marks the First Anniversary of Availability of the Only FDA Approved Corneal Cross-Linking Treatment in The U.S.

08:00 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
One Year Since Launch, 10,000 Procedures Have Been Completed, Insurance Coverage Has Significantly Expanded Avedro, Inc., today marked the one year anniversary of the U.S. commercial availability of Photrexa Viscous®...

Other Sources for this Article

Avedro Contact:
Avedro, Inc.
David Iannetta, 781-768-3400
info@avedro.com
or
Media Contact:
BioComm Network, Inc.
Michele Gray, 917-449-9250
michele_gray@me.com

NEXT ARTICLE

More From BioPortfolio on "Avedro Marks the First Anniversary of Availability of the Only FDA Approved Corneal Cross-Linking Treatment in The U.S."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...